personalized medicine
Three biotech trends shaping pharma's digital economy
February 16 by Emily Uwemedimo
Find out how biotech can speed up drug development, make products cheaper to produce and provide more effective medicines for patients
A key step for the future of personalized medicine: CRISPR immunity and Mathematical Cryptanalysis.
April 02 by Michael A. PopovIn this analysis, Michael A. Popov, Director Researcher at Prime States Quantum Lab looks at the future trends and applications of the CRISPR Cas9 tool
UCI announces immunotherapy technique to specifically target tumor cells
November 12 by Pharmaceuticals & Biotechnology EditorUCI and Caltech's latest "lab on a chip" technology could be used to create individualized treatments for cancer
Personalized Medicine –A Game with More Than One Nash Equilibrium
January 12 by Cristina FalcãoThere is a time and the time is now and is right for me… (1) Welcome to the age of personalized medicine. With the mapping of the entire human genome, completed in 2003, many doors were un...
Orphan Drugs – Reinventing Economies of Scale
November 16 by Cristina FalcãoEconomies of scale come in many flavors. Including the oddity flavor where the number of manufactured products decreases and the size of markets shrink. Orphan drugs are economies of scale’...
Achieving the 4 Rights in Effective Health Care: An Interview with Peter Pitts
January 07 by Andrea CharlesAs part of the new Pharma Leaders Today series, Peter Pitts, President and co-founder of the Center for Medicine in the Public Interest and Partner/Director Global Healthcare, Porter Novelli,&nbs...
Is Co-development the Best Method for Companion Diagnostics?
April 04 by Paul de KoningPaul de Koning, Vice President, Head Global Clinical Pharmacology & Exploratory Development, Astellas Pharma Global Development, joins Pharma IQ to discuss targeted treatment and diagnostics....
